← back to search

Katherine N. Weilbaecher

National Center for Tumor Diseases ·
Area of research
Oncology · Immunology and Allergy
Research interest
Research interests include Medicine, Internal medicine, Biology, Metastatic breast cancer, Eribulin, and Tolerability.
h-index
citations
294
works
5
NIH funding
primary concept
email

Recent publications

Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19
Journal of Virology 2022cited by 28position: lastdoi
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis
European Journal of Cancer 2021cited by 50position: middledoi
Assessment of Copper Nanoclusters for Accurate in Vivo Tumor Imaging and Potential for Translation
ACS Applied Materials & Interfaces 2019cited by 48position: middledoi
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial
The Lancet Oncology 2018cited by 136position: middledoi
The β3‐integrin endothelial adhesome regulates microtubule‐dependent cell migration
EMBO Reports 2018cited by 32position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

John F. DiPersio · Bluebird Bio (United States)1 papers (2022–2022) · 1 papers (2022–2022)Mijia Lu · The Ohio State University1 papers (2022–2022)Lee Ratner · Molecular Oncology (United States)1 papers (2022–2022)Ingrid A. Mayer · AstraZeneca (Netherlands)1 papers (2018–2018)Marta Gil-Martín · Universitat de Barcelona1 papers (2018–2018) · 1 papers (2022–2022)Ralph D. Sanderson · University of Alabama at Birmingham1 papers (2022–2022)Babak Razani · University of Pittsburgh1 papers (2019–2019)Karen L. Wooley · Mitchell Institute1 papers (2019–2019) · 1 papers (2019–2019)Samson Fung · Intermolecular (United States)1 papers (2018–2018)José Manuel Pérez-García · Asociación Española Contra el Cáncer1 papers (2018–2018)Gyu Seong Heo · University of Missouri1 papers (2019–2019)Yongfeng Zhao · Drexel University1 papers (2019–2019)Xiangyu Zhang · Shandong University1 papers (2019–2019)Jiànróng Lǐ · University of Arizona1 papers (2022–2022)Miguel Martín · Spanish Ovarian Cancer Research Group1 papers (2018–2018)Yongjian Liu · Beijing University of Chinese Medicine1 papers (2019–2019) · 1 papers (2022–2022)